Trinity Biotech Announces Q3 2024 Financial Results
Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV […]
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
Landstar Announces Enhancements to Leadership Team
JACKSONVILLE, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR) (“Landstar” or the “Company”), a technology-enabled, asset-light provider […]
SoDA and Wix Studio Present a Special Edition of The SoDA Report On: The Role of Storytelling in Creating Modern Web Experiences
The report highlights how agencies can embrace storytelling to showcase innovation, differentiate themselves, and integrate new technologies NEW YORK, November […]
Outset Medical to Present at the 2024 Stifel Healthcare Conference
SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering […]
Fortinet Expands Global Presence with New Company-Owned Innovation Hub in Atlanta
ATLANTA, Nov. 15, 2024 (GLOBE NEWSWIRE) — John Whittle, Chief Operating Officer at Fortinet “With our new space in Atlanta […]
Lucas GC Limited Participated In Drafting Industry Standard for Green Intelligent Computing Center
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) — Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence […]
Onfolio Holdings Inc. Announces Third Quarter 2024 Financial Results and Provides Corporate Update
WILMINGTON, Del., Nov. 15, 2024 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTCQB: ONFOP) (“Onfolio” or the “Company”), […]
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
PALO ALTO, Calif. , Nov. 15, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative […]
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy […]
